Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

ETHICON ENDO-SURGERY

Ethicon Endo-Surgery, Inc. a subsidiary of the Johnson & Johnson group of companies, develops, manufactures, and mark... read more Featured Products: More products

Download Mobile App




Adjunctive Hemostatic Solution Controls Oozing Blood

By HospiMedica International staff writers
Posted on 28 Aug 2017
An absorbable hemostatic powder comprised of oxidized regenerated cellulose (ORC) offers quick surface coverage with an easy-to-use applicator.

The Ethicon (Somerville, NJ, USA) Surgicel Powder Absorbable Hemostat uses proprietary plant-based ORC technology to provide a polyanhydroglucuronic acid (PAGA) hemostatic solution that penetrates oozing blood, quickly stopping bleeding at the source. More...
The exact mechanism of is poorly understood, but is believed to promote coagulation physically, rather than by triggering the physiological clotting mechanism, and also by encouraging platelets to adhere and aggregate. The resulting coagulation clot stays intact even when the surgical field is irrigated.

Surgicel Powder Absorbable Hemostat also provides bactericidal coverage against a range of gram-positive and gram-negative organisms, including methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus faecalis (VRE), penicillin-resistant Streptococcus pneumoniae (PRSP), and Methicillin-resistant Staphylococcus epidermidis (MRSE). Absorption commences within 24 hours, and within one week multinucleated giant cells are observed. After four to eight weeks they disappear together with the Surgicel.

“This new and innovative approach to applying ORC, combined with the proven track record of the Surgical brand, will give surgeons an ideal solution to control oozing bleeding on broad surfaces during surgeries,” said Oray Boston, worldwide vice president and Biosurgery platform leader at Ethicon.

Cellulose is a homopolysaccharide that can be either regenerated to form organized fibers or remain non-regenerated with unorganized fibers prior to oxidation. Polyuronic acid is the main component of oxidized cellulose, with nonoxidized hydroxyl groups remaining as a fibrous component. The oxidization process gives oxidized cellulose its hemostatic and bactericidal properties; the low pH of the carboxylic acid groups generates a primary local styptic action, a secondary platelet activation to form a temporary platelet plug, and conditions under which most bacteria cannot survive.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.